NIGONIX’S MISSION IS TO DETECT CANCER EARLY,
WHEN IT CAN BE CURED
WHAT IS NIGONIX?
Nigonix is a cancer screening test that uses highly sensitive factory sensory functions of nematodes. This novel test that employs natural capabilities of organism is not invasive, causes no pain and can be used for early detection.
Taking a cancer test regularly can reduce stress and prevent late stage decease developmement.
Early detection leads to cure.
CANCER INCIDENCE AND MORTALITY RATE
Cancer is a major cause of death worldwide, and it is estimated that 9.6 million people died from cancer
People often die from cancer because it is too advanced to be treated when detected. However, cancers that are detected early are more likely to respond positively to medical treatment, resulting in low mortality rate.
Screening is performed to identify people who may have a specific cancer and are in a precancerous state still without clinical manifestations.
Types of cancer that NIGONiX has been known to be able to detect
Nematodes are known to respond to the types of cancer shown below (as of August 2019):
Stomach, colorectal, lung, breast, pancreatic, liver, prostate, uterine, esophageal, gall bladder, bile duct, kidney, bladder, ovarian, oral/pharyngeal
— 15 types of cancer
Survival rates are higher when cancer is diagnosed at earlier stages. However, effective screening only exists for a few cancer types, and most cancer is detected at later stages, when survival rates are much lower.
Transform cancer care
through early detection
Our mission is to improve and save lives through early cancer detection, and we are developing our test in a rigorous way to deliver our test to patients safely and effectively.
We’re unrelenting in the pursuit of our mission and will not stop until we find a better way.
With the best talent in biology,clinical science, bioinformatics, deep learning, and engineering, our goal is to greatly decrease global cancer mortality.